CUSIP 38000Q102COMGLYCEURQ1 2025
33 filings · latest Feb 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bvf Inc/Il | 9.54M | $2.00M |
| 2 | Logos Global Management LP | 5.40M | $1.13M |
| 3 | Adage Capital Partners Gp, L.L.C. | 5.09M | $1.07M |
| 4 | Vr Adviser, LLC | 3.00M | $630.0K |
| 5 | Vanguard Group Inc | 2.67M | $560.7K |
| 6 | Wellington Management Group LLP | 1.37M | $287.8K |
| 7 | Blackrock, Inc. | 726.3K | $152.5K |
| 8 | Jefferies Financial Group Inc. | 585.0K | $122.8K |
| 9 |
| 4 | Nov 6, 2024 | Ra Capital Management, L.P. | 13G | 9.9% | 6.38M | SEC |
| 5 | Nov 4, 2024 | Weinstein Benjamin | 13G/A | 0.1% | 50.0K | SEC |
| 6 | Nov 4, 2024 | Adage Capital Management, L.P. | 13D | 7.9% | 5.09M | SEC |
| 7 | Aug 15, 2024 | Invus Global Management, LLC | 13G/A | 8.2% | 5.29M | SEC |
| 8 | Aug 14, 2024 | Weinstein Benjamin | 13G | 5.3% | 3.40M | SEC |
| 9 | Jul 29, 2024 | Invus Global Management, LLC | 13G/A | 13.3% | 8.59M | SEC |
| 10 | May 8, 2024 | New Enterprise Associates 10 L P | 13D/A | — | — | SEC |
See the full Schedule 13D/13G history for Glycomimetics Inc.
Unlock full history| 571.7K |
| $120.1K |
| 10 | Ubs Group AG | 465.9K | $97.8K |